InstalabPhysician-backed insights to optimize your health and reduce long-term risks.
Yes. In two large trials published in August 2026, about half of adults with at least half the scalp bare regrew hair to near-normal coverage after 24 weeks, and a meaningful minority regrew it all. That's the strongest response any oral JAK inhibitor has posted in severe alopecia areata. The catch: the hair holds only while you keep taking the pill, and Rinvoq still carries the JAK class boxed warning for infections, clots, and cancer.
Something new is within reach for celiac disease: an add-on drug that could make accidental gluten less damaging to your gut. One pill, ZED1227, has already shown in people that it blunts the intestinal injury gluten causes during a controlled gluten challenge. That is meaningful progress. It is also not a cure, and not a license to eat bread. The gluten-free diet is still the only proven treatment, and the useful move now is to know which therapies have human proof behind them and which are still earlier signals.